Ionis Pharmaceuticals IONS Accrued Liabilities, Current
Accrued Liabilities, Current at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.
The official record: Ionis Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's accrued liabilities, current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ionis Pharmaceuticals's accrued liabilities, current?
- Ionis Pharmaceuticals (IONS) reported accrued liabilities, current of $126.55M in Q1 2026.
- How has Ionis Pharmaceuticals's accrued liabilities, current changed year-over-year?
- Ionis Pharmaceuticals's accrued liabilities, current increased by 23.2% year-over-year, from $102.74M to $126.55M.
- What is the long-term trend for Ionis Pharmaceuticals's accrued liabilities, current?
- Over 5 years (2020 to 2025), Ionis Pharmaceuticals's accrued liabilities, current has grown at a 3.3% compound annual growth rate (CAGR), from $90.16M to $106.09M.